AJOB Volume 24, Issue 10
Related posts
Who Deserves Ozempic?
There isn’t enough Ozempic for everyone who wants it. People with health conditions like type 2 diabetes and severe obesity should get it before people who hope to lose a few pounds. As the new ‘miracle drug’ for weight loss, Ozempic is one of the most popular new drugs in America. This has come mostly from the media, […]
Bioethics, Equity, and Inclusion: How Do We Not Add to the Minority Tax?
This editorial appears in the October 2024 issue of the American Journal of Bioethics As a Black bioethicist whose primary area of expertise is anti-Black racism’s influence on our health, I read articles calling on bioethics to do a better job of promoting anti-racist principles and policies such as Lee’s “Racial Equity, Diversity and Inclusion […]
On Opportunities And Challenges For Applying Multi-Modal AI In Organ Transplantation, Part II
This essay is part II of a two-part series. See part I, here: https://bioethicstoday.org/blog/on-opportunities-and-challenges-for-applying-multi-modal-ai-in-organ-transplantation-part-i/ In the last few years, artificial intelligence (AI) techniques have been used in organ transplantation (OTx). A PubMed search using the terms ((transplant) AND (artificial intelligence)) AND (ethics) returned 79 citations, most in the last two years. AI was used to […]
In Memoriam: Dr. Howard A. Brody
Dr. Howard A. Brody’s remarkable career was defined by an extensive commitment to exploring the intersection of medicine, ethics, and humanism. He led the Institute for the Medical Humanities at the University of Texas Medical Branch and the Center for Ethics and Humanities in the Life Sciences at Michigan State University. His tenure at MSU […]